Recently in Food and Drug Administration Category

January 28, 2026

Pharmaceutical Companies Are Responsible for the Most Federal Fraud Lawsuits Filed in the U.S.

Q: What Industry do you think is the leader in Federal Fraud Lawsuits in the United States?
A: Pharmaceutical Industries.


Photo credit: mconnors from morguefile.com

According to a report released by Public Citizens in December 2010, one out of every four dollars collected by the U.S. government due to fraud charges under the False Claims Act comes from pharmaceutical companies. The report shows that Drug Companies are the leader in Federal Fraud Lawsuits. Defense Companies accounted for 11% of fraud settlements, this makes them the second highest in federal fraud lawsuits, in the United States.

Public Citizen was founded in 1971 and serves as the people's voice in the nations capital. It is a nonprofit organization responsible for being the voice of many in all aspects of the government. They go before Congress, the executive branch agencies and the court systems. They challenge various agencies, such as pharmaceutical, nuclear and automotive industries.

The report analyzed civil and criminal settlements under the False Claims Act at the state and federal levels since 1991 in order to determine the leaders in federal fraud suits.

The False Claims Act is a law that allows people who are not affiliated with the government to file actions against federal contractors they accuse of committing claims fraud against the government. People who file under the Act stand to receive a portion of any recovered damages. This act provides a legal tool to counteract fraudulent billings turned in to the federal government. The original False Claims Act was passed in 1863 and it has since been revised. The last revision was in 1986 and since then almost $22 billion has been recovered by the federal government.

Out of the almost $22 billion recovered since 1986, 75% of the money and 73% of the cases happened in the last 5 years. The U.S. Department of Justice (DOJ) files most of these fraud cases that are brought against the pharmaceutical companies. Most of these cases are for attempting to market medications that have not yet been approved by the U.S. Food and Drug Administration (FDA). It is illegal under federal drug regulations for a company to promote their products that have not been approved by the FDA.

In 2009, Pfizer was fined $1.2 billion for illegally marketing the painkiller Bextra. This is currently the largest criminal fraud fine in history. The second highest was Elan Pharmaceuticals. It was fined $203 million for illegally marketing the epilepsy drug Zonegram.

Bookmark and Share
April 12, 2026

Prescription Drug Poisoning Has Surpassed Automobile Accidents As the Leading Cause of Unintentional Injury Deaths

In a report by the American Journal of Preventative Medicine, prescription drug poisoning now surpasses automobile accidents as the leading cause of unintentional injury death among people of ages 35 to 54.

Currently the number of people that are hospitalized due to overdoses from prescription drugs is 65% higher than they were between 1999 and 2006. Such drugs are OxyContin, Fentanyl and Morphine. The use of these drugs, whether illegally or as a suicide attempt rose 130% and accidental overdoses rose by 37%. No other prescription drug causes such a high occurrence of hospitalizations in the United States, according to Researchers from the West Virginia University School of Medicine.

Overdoses from drugs such as tranquilizers, sedatives and painkillers, has also risen by 65% in the last couple of years, making drug poisoning the second leading cause of unintentional injury death in the U.S.

In 2009, an average of 71,000 people, were hospitalized for painkiller overdoses. This is a huge increase from the 43,000 people that were hospitalized in 2008. Methadone is the drug that saw the largest increase in poisoning hospitalizations. Among other drugs that saw an increase in hospitalization is Valium, which saw a 39% increase. Barbiturates and antidepressants actually saw a decrease.

It is due to these huge increases in drug overdoses that caused the Food and Drug Administration (FDA) to approve a new tamper-resistant version of OxyContin. This new version of the drug is supposed to resist the efforts to cut, chew, or crush the pills in order to defeat the slow medication release design of the pills.

Bookmark and Share
April 7, 2026

Human Factors Experts Testimony in Product Liability Cases Is On the Rise

The Food and Drug Administration (FDA) has regulations, guidance documents and industry standards in relation to the use of human factors experts, which allow for more effective cross-examination and a strong defense in Product Liability Cases. With these regulations, human factors not only base their expert opinion on speculation, but also on facts.

You may be asking yourself, what are Human Factors, well it is the study of the relationships between humans, the tools they use, and the environment in which they live and work.

It is with these tools that human factors experts are allowed to testify in cases to provide opinions regarding the adequacy and efficacy of warnings and/or the impact of human factors in the design of products. The Expert must be able to identify a reliable scientific basis for his/her opinion to be used as testimony. It is the goal of the human factors professional to eliminate user error through proper product design and labeling.

Medical devices that are designed by the FDA are designed with the human factor principles in mind. According to the FDA manufacturers must use the following three device classes/guidelines when manufacturing a device for human use:

- The Manufacturer must consider human factors in the development of the device. Such things as what the user sees, feels and hears;
- The Manufacturer must test all devices for the potential in error use by the user;
- The Manufacturer, when conducting risk analysis of the device, must consider user error.

These three device classes must all be subject to good manufacturing practices (GMPs) and these can be found in its Quality System Regulations. It is imperative that the medical device withstand the actions and inactions of its intended user, in order to design an error-tolerant medical device. It is important that the developer consider the characteristics of the worst case user. It is this underlying philosophy that human factor experts are used for.

These Human Factors Principles are also embraced by the Association for the Advancement of Medical Instruments (AAMI), the International Electrotechnical Commission (IEC) and the International Organization for Standardization (ISO)

Bookmark and Share
April 1, 2026

The Food and Drug Administration Ignored CT Scan Radiation Warnings

In Gaithersburg, Maryland today there will be a two day public hearing to discuss allegations that the FDA ignored some Scientists warnings on the risks of radiation exposure from CT scans that have lead to unnecessary and unexpected health problems and dangers to some patients.

The public hearing will focus on reducing the risks of unnecessary radiation exposure. The concerns about radiation exposure risks came about late last year in Los Angeles, California, when over 200 patients were subjected to radiation overexposure at Cedars-Sinai Medical Center. It was uncovered by the FDA that various cases at other area hospitals were discovered. These discoveries by the FDA lead to a new radiation exposure reduction initiative that was announced in February of this year.

This new initiative seeks to reduce the risk of radiation exposure from medical procedures by promoting the safer use of all medical devices that use radiation, and by providing support to patients in order to better inform them on the risks and side effects to radiation exposure. With this knowledge, patients will be able to make better decisions in regards to their medical procedures and be aware of their total radiation exposure.

The FDA issued a statement in December 2009 that better describes the side effects of radiation and the proper use of medical devices to health care professionals and radiologists. This guidance advised health care providers to review procedures and CT scan settings, and to thoroughly inspect the amount of dosage prescribed for each CT scan patient.

Bookmark and Share